What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
Debabrata Mukherjee mainly investigates Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery.
His Internal medicine study deals with Endocrinology intersecting with Ischemic cardiomyopathy.
The Coronary artery disease and Unstable angina research he does as part of his general Cardiology study is frequently linked to other disciplines of science, such as Task force, therefore creating a link between diverse domains of science.
His work on Acute coronary syndrome and Revascularization as part of his general Myocardial infarction study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Debabrata Mukherjee has researched Percutaneous coronary intervention in several fields, including Platelet aggregation inhibitor, Conventional PCI, Angioplasty, Guideline and ST segment.
His studies examine the connections between Surgery and genetics, as well as such issues in Hazard ratio, with regards to End stage renal disease, Proportional hazards model, Kidney disease, Hemodialysis and Cohort.
His most cited work include:
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) (5768 citations)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions (2628 citations)
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (1795 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Surgery and Percutaneous coronary intervention.
Stroke, Coronary artery disease, Acute coronary syndrome, Revascularization and Randomized controlled trial are subfields of Internal medicine in which his conducts study.
Debabrata Mukherjee works mostly in the field of Cardiology, limiting it down to topics relating to Odds ratio and, in certain cases, Confidence interval, as a part of the same area of interest.
The study incorporates disciplines such as Artery, Vascular disease and Intensive care medicine in addition to Myocardial infarction.
His Intensive care medicine research is multidisciplinary, incorporating elements of Disease and MEDLINE.
His Percutaneous coronary intervention research includes elements of Platelet aggregation inhibitor, Guideline and Conventional PCI.
He most often published in these fields:
- Internal medicine (61.29%)
- Cardiology (46.61%)
- Myocardial infarction (20.81%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (61.29%)
- Cardiology (46.61%)
- Myocardial infarction (20.81%)
In recent papers he was focusing on the following fields of study:
Debabrata Mukherjee focuses on Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery.
His work is connected to Odds ratio, Stroke, Randomized controlled trial, Meta-analysis and Heart failure, as a part of Internal medicine.
His research investigates the connection between Heart failure and topics such as Intensive care medicine that intersect with problems in MEDLINE, Disease, Treatment options and Clinical trial.
The various areas that he examines in his Cardiology study include Guideline and Kidney disease.
His Myocardial infarction study frequently draws connections to adjacent fields such as Framingham Risk Score.
His research on Percutaneous coronary intervention also deals with topics like
- Conventional PCI and related Artery,
- Acute coronary syndrome that connect with fields like Aspirin.
Between 2015 and 2021, his most popular works were:
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (906 citations)
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction (433 citations)
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (291 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Randomized controlled trial and Surgery.
His Internal medicine study typically links adjacent topics like Alternative medicine.
His study brings together the fields of Guideline and Cardiology.
His work focuses on many connections between Myocardial infarction and other disciplines, such as Framingham Risk Score, that overlap with his field of interest in Perioperative.
His work carried out in the field of Randomized controlled trial brings together such families of science as Clinical trial, Lower risk, Thrombolysis, Intermediate risk and Meta-analysis.
His research in Percutaneous coronary intervention intersects with topics in Conventional PCI and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
